ORAL CHEMOTHERAPY IN TREATMENT OF PATIENTS WITH MALIGNANCIES OF MOST COMMON LOCALIZATIONS

Chorny V.A., Osinskiy D.S., Lyashko T.V., Sen’ko L.N.

Findings are discussed of the clinical trials aiming to assets the efficacy of capecitabins in monochemotherapy and on combinations with other anti-tumor drugs and the treatment of patients with malignancies of most common localizations. The analysis of findngs gives grounds to conclude that capecitabin is promising for treatment of breast cancer, colorectal cancer, stomach cancer, and some other malignancies with account for pronounced anti-tumor effect and moderate manifestations of the system toxicity.